Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-04

FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)

Snippet

ORIG AP for ALBENDAZOLE (ALBENDAZOLE)